Table 4 Drug susceptibility analysis according to NDUFAF6
From: Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
Drug | cor | pvalue |
|---|---|---|
Nelarabine | 0.4567 | 0.0002 |
Chelerythrine | 0.4561 | 0.0002 |
Vorinostat | 0.3993 | 0.0016 |
Ifosfamide | 0.3457 | 0.0068 |
PX-316 | 0.3379 | 0.0083 |
Belinostat | 0.3048 | 0.0179 |
Amonafide | 0.2746 | 0.0338 |